1 – 3 of 3
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock : A randomized crossover double-blind study
- 2017
- Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients
- 2014
- How to assess prognosis after cardiac arrest and therapeutic hypothermia